TrialClinical rheumatology2017

Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.

Vinod Ravindran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.